{
  "name": "FDA Philippines advisories naming research peptides",
  "description": "FDA Philippines advisories that name a compound in the Primara Labs catalogue, with number, date, a one-sentence factual summary and a link. Only advisories that could be opened are listed.",
  "source": "https://www.primaralabs.com/research/status",
  "lastUpdated": "2026-09-23",
  "licence": "Free to reuse with a link to the source page.",
  "schema": [
    {
      "key": "number",
      "type": "string",
      "description": "Advisory number as published."
    },
    {
      "key": "date",
      "type": "date",
      "description": "Date of the advisory."
    },
    {
      "key": "compounds",
      "type": "string",
      "description": "Listed compounds the advisory names."
    },
    {
      "key": "summary",
      "type": "string",
      "description": "One factual sentence."
    },
    {
      "key": "sourceUrl",
      "type": "url",
      "description": "The primary source the row was read from."
    },
    {
      "key": "checkedOn",
      "type": "date",
      "description": "ISO date the source was last read."
    }
  ],
  "rowCount": 3,
  "rows": [
    {
      "number": "FDA Advisory No. 2026-0814",
      "date": "2026-07-30",
      "compounds": "Tirzepatide",
      "summary": "FDA Philippines warned the public against buying or using an unregistered tirzepatide product sold as Tirz Laine Tirzepatide 30mg/3 mL, which had not been issued a Certificate of Product Registration.",
      "sourceUrl": "https://www.fda.gov.ph/fda-advisory-no-2026-0814-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-tirz-laine-tirzepatide-30mg-3-ml-99-purity/",
      "checkedOn": "2026-09-23"
    },
    {
      "number": "FDA Advisory No. 2026-1019",
      "date": "2026-09-04",
      "compounds": "Tirzepatide",
      "summary": "FDA Philippines warned the public against buying or using an unregistered tirzepatide product sold as Peptatide Tirzepatide 15mg with a bacteriostatic water kit, which had not been issued a Certificate of Product Registration.",
      "sourceUrl": "https://www.fda.gov.ph/fda-advisory-no-2026-1019-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-peptatide-tirzepatide-for-subcutaneously-use-only-15mg-and-peptatide-bacterios/",
      "checkedOn": "2026-09-23"
    },
    {
      "number": "FDA Advisory No. 2025-1200",
      "date": "2025-11-06",
      "compounds": "Semaglutide",
      "summary": "FDA Philippines published updates to its list of VAT-exempt health products under the CREATE Act, including seven semaglutide solutions for injection listed under drugs for diabetes.",
      "sourceUrl": "https://www.fda.gov.ph/fda-advisory-no-2025-1200-endorsement-of-updates-on-the-list-of-vat-exempt-health-products/",
      "checkedOn": "2026-09-23"
    }
  ]
}